Cytori Therapeutics (San Diego) reported receiving its first orders from Europe and Asia for Celution 800 Systems. Eleven Celution 800 Systems and related CT-805 single-use consumables were ordered by Cytori’s distributors MBA Grupo, which covers Spain, Italy, and Portugal, and Astrea International, which covers Singapore. Cytori says the first devices are to be delivered this quarter.

"These opening orders mark a key transition for the company and its products," said Christopher Calhoun, Cytori CEO. "We achieved our stated goal from last year, which was to accelerate our product introduction to early 2008 by bringing an innovative reconstructive surgery product to physicians and their patients."

Cytori has regulatory approval for the Celution 800 System in Europe, is seeking clearances in Asia-Pacific, and has forged commercialization partnerships with distributors in these markets.